Douglas Pharmaceuticals Europe Limited
Douglas Pharmaceuticals Europe Limited, a prominent player in the pharmaceutical industry, is headquartered in New Zealand (NZ) and operates extensively across Europe. Founded in 1990, the company has established itself as a leader in the development and manufacturing of high-quality generic and branded pharmaceuticals.
With a focus on prescription medications, Douglas Pharmaceuticals is renowned for its commitment to innovation and quality, offering a diverse range of products that cater to various therapeutic areas. The company’s unique approach to formulation and production has positioned it favourably within the competitive landscape.
Notable achievements include a robust portfolio of products that meet stringent regulatory standards, ensuring safety and efficacy for patients. Douglas Pharmaceuticals continues to expand its market presence, driven by a dedication to improving health outcomes across Europe and beyond.
-15 vs industry average
Douglas Pharmaceuticals Europe Limited’s score of 21 is lower than 20% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Douglas Pharmaceuticals Europe Limited?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Retail Trade Services has below-average carbon intensity
Industry performance
The Retail Trade Services industry has reduced its overall emissions by 31% since 2018
Reported emissions
No reported emissions data is available for Douglas Pharmaceuticals Europe Limited yet.
Douglas Pharmaceuticals Europe Limited's reported carbon emissions
Douglas Pharmaceuticals Europe Limited, headquartered in New Zealand, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company.
As a result, Douglas Pharmaceuticals Europe Limited appears to be in the early stages of establishing its climate commitments and emissions reporting. Without specific emissions data or reduction initiatives, it is unclear how the company plans to address its carbon footprint or align with industry standards for sustainability.
In the context of the pharmaceutical industry, companies are increasingly expected to set science-based targets and engage in transparent reporting of their emissions. As Douglas Pharmaceuticals Europe Limited develops its climate strategy, it may consider adopting such practices to enhance its environmental responsibility and align with global climate goals.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Douglas Pharmaceuticals Europe Limited’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Douglas Pharmaceuticals Europe Limited yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Douglas Pharmaceuticals Europe LimitedUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project